Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Measuring ex vivo drug susceptibility in Plasmodium vivax isolates from Cambodia.

Chaorattanakawee S, Lon C, Chann S, Thay KH, Kong N, You Y, Sundrakes S, Thamnurak C, Chattrakarn S, Praditpol C, Yingyuen K, Wojnarski M, Huy R, Spring MD, Walsh DS, Patel JC, Lin J, Juliano JJ, Lanteri CA, Saunders DL.

Malar J. 2017 Sep 30;16(1):392. doi: 10.1186/s12936-017-2034-2.

2.

Association of a Novel Mutation in the Plasmodium falciparum Chloroquine Resistance Transporter With Decreased Piperaquine Sensitivity.

Agrawal S, Moser KA, Morton L, Cummings MP, Parihar A, Dwivedi A, Shetty AC, Drabek EF, Jacob CG, Henrich PP, Parobek CM, Jongsakul K, Huy R, Spring MD, Lanteri CA, Chaorattanakawee S, Lon C, Fukuda MM, Saunders DL, Fidock DA, Lin JT, Juliano JJ, Plowe CV, Silva JC, Takala-Harrison S.

J Infect Dis. 2017 Aug 15;216(4):468-476. doi: 10.1093/infdis/jix334.

3.

Utility of the Nanosphere Verigene in the Identification of Bacteremia Isolates From the Burn Intensive Care Unit.

Farmer A, Lanteri CA, Steele E, Mende K, Pamplin J, Akers KS.

Mil Med. 2017 Sep;182(9):e1779-e1784. doi: 10.7205/MILMED-D-17-00018.

PMID:
28885937
4.

Partner-Drug Resistance and Population Substructuring of Artemisinin-Resistant Plasmodium falciparum in Cambodia.

Parobek CM, Parr JB, Brazeau NF, Lon C, Chaorattanakawee S, Gosi P, Barnett EJ, Norris LD, Meshnick SR, Spring MD, Lanteri CA, Bailey JA, Saunders DL, Lin JT, Juliano JJ.

Genome Biol Evol. 2017 Jun 1;9(6):1673-1686. doi: 10.1093/gbe/evx126.

5.

Single dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission in Cambodia: An open-label randomized trial.

Lin JT, Lon C, Spring MD, Sok S, Chann S, Ittiverakul M, Kuntawunginn W, My M, Thay K, Rahman R, Balasubramanian S, Char M, Lanteri CA, Gosi P, Ubalee R, Meshnick SR, Saunders DL.

PLoS One. 2017 Jun 7;12(6):e0168702. doi: 10.1371/journal.pone.0168702. eCollection 2017.

6.

Selective sweep suggests transcriptional regulation may underlie Plasmodium vivax resilience to malaria control measures in Cambodia.

Parobek CM, Lin JT, Saunders DL, Barnett EJ, Lon C, Lanteri CA, Balasubramanian S, Brazeau N, DeConti DK, Garba DL, Meshnick SR, Spring MD, Chuor CM, Bailey JA, Juliano JJ.

Proc Natl Acad Sci U S A. 2016 Dec 13;113(50):E8096-E8105. Epub 2016 Nov 28.

7.

Genetic diversity among Plasmodium vivax isolates along the Thai-Myanmar border of Thailand.

Maneerattanasak S, Gosi P, Krudsood S, Tongshoob J, Lanteri CA, Snounou G, Khusmith S.

Malar J. 2016 Feb 9;15:75. doi: 10.1186/s12936-016-1136-6.

8.

Attenuation of Plasmodium falciparum in vitro drug resistance phenotype following culture adaptation compared to fresh clinical isolates in Cambodia.

Chaorattanakawee S, Lanteri CA, Sundrakes S, Yingyuen K, Gosi P, Chanarat N, Wongarunkochakorn S, Buathong N, Chann S, Kuntawunginn W, Arsanok M, Lin JT, Juliano JJ, Tyner SD, Char M, Lon C, Saunders DL.

Malar J. 2015 Dec 2;14:486. doi: 10.1186/s12936-015-1021-8.

9.

Ex Vivo Drug Susceptibility Testing and Molecular Profiling of Clinical Plasmodium falciparum Isolates from Cambodia from 2008 to 2013 Suggest Emerging Piperaquine Resistance.

Chaorattanakawee S, Saunders DL, Sea D, Chanarat N, Yingyuen K, Sundrakes S, Saingam P, Buathong N, Sriwichai S, Chann S, Se Y, Yom Y, Heng TK, Kong N, Kuntawunginn W, Tangthongchaiwiriya K, Jacob C, Takala-Harrison S, Plowe C, Lin JT, Chuor CM, Prom S, Tyner SD, Gosi P, Teja-Isavadharm P, Lon C, Lanteri CA.

Antimicrob Agents Chemother. 2015 Aug;59(8):4631-43. doi: 10.1128/AAC.00366-15. Epub 2015 May 26.

10.

Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study.

Spring MD, Lin JT, Manning JE, Vanachayangkul P, Somethy S, Bun R, Se Y, Chann S, Ittiverakul M, Sia-ngam P, Kuntawunginn W, Arsanok M, Buathong N, Chaorattanakawee S, Gosi P, Ta-aksorn W, Chanarat N, Sundrakes S, Kong N, Heng TK, Nou S, Teja-isavadharm P, Pichyangkul S, Phann ST, Balasubramanian S, Juliano JJ, Meshnick SR, Chour CM, Prom S, Lanteri CA, Lon C, Saunders DL.

Lancet Infect Dis. 2015 Jun;15(6):683-91. doi: 10.1016/S1473-3099(15)70049-6. Epub 2015 Apr 12.

PMID:
25877962
11.

Ex vivo activity of endoperoxide antimalarials, including artemisone and arterolane, against multidrug-resistant Plasmodium falciparum isolates from Cambodia.

Lanteri CA, Chaorattanakawee S, Lon C, Saunders DL, Rutvisuttinunt W, Yingyuen K, Bathurst I, Ding XC, Tyner SD.

Antimicrob Agents Chemother. 2014 Oct;58(10):5831-40. doi: 10.1128/AAC.02462-14. Epub 2014 Jul 21.

12.

Blackwater fever in an uncomplicated Plasmodium falciparum patient treated with dihydroartemisinin-piperaquine.

Lon C, Spring M, Sok S, Chann S, Bun R, Ittiverakul M, Buathong N, Thay K, Kong N, You Y, Kuntawunginn W, Lanteri CA, Saunders DL.

Malar J. 2014 Mar 14;13:96. doi: 10.1186/1475-2875-13-96.

13.

Evaluation of parasite subpopulations and genetic diversity of the msp1, msp2 and glurp genes during and following artesunate monotherapy treatment of Plasmodium falciparum malaria in Western Cambodia.

Gosi P, Lanteri CA, Tyner SD, Se Y, Lon C, Spring M, Char M, Sea D, Sriwichai S, Surasri S, Wongarunkochakorn S, Pidtana K, Walsh DS, Fukuda MM, Manning J, Saunders DL, Bethell D.

Malar J. 2013 Nov 9;12:403. doi: 10.1186/1475-2875-12-403.

14.

Development of a capillary electrophoresis-based heteroduplex tracking assay to measure in-host genetic diversity of initial and recurrent Plasmodium vivax infections in Cambodia.

Givens MB, Lin JT, Lon C, Gosi P, Char MC, Lanteri CA, Saunders DL, Juliano JJ.

J Clin Microbiol. 2014 Jan;52(1):298-301. doi: 10.1128/JCM.02274-13. Epub 2013 Oct 16.

15.

Direct comparison of the histidine-rich protein-2 enzyme-linked immunosorbent assay (HRP-2 ELISA) and malaria SYBR green I fluorescence (MSF) drug sensitivity tests in Plasmodium falciparum reference clones and fresh ex vivo field isolates from Cambodia.

Chaorattanakawee S, Tyner SD, Lon C, Yingyuen K, Ruttvisutinunt W, Sundrakes S, Sai-gnam P, Johnson JD, Walsh DS, Saunders DL, Lanteri CA.

Malar J. 2013 Jul 12;12:239. doi: 10.1186/1475-2875-12-239.

16.

A chemotype that inhibits three unrelated pathogenic targets: the botulinum neurotoxin serotype A light chain, P. falciparum malaria, and the Ebola filovirus.

Opsenica I, Burnett JC, Gussio R, Opsenica D, Todorović N, Lanteri CA, Sciotti RJ, Gettayacamin M, Basilico N, Taramelli D, Nuss JE, Wanner L, Panchal RG, Solaja BA, Bavari S.

J Med Chem. 2011 Mar 10;54(5):1157-69. doi: 10.1021/jm100938u. Epub 2011 Jan 25.

17.

Design of anti-parasitic and anti-fungal hydroxy-naphthoquinones that are less susceptible to drug resistance.

Hughes LM, Lanteri CA, O'Neil MT, Johnson JD, Gribble GW, Trumpower BL.

Mol Biochem Parasitol. 2011 May;177(1):12-9. doi: 10.1016/j.molbiopara.2011.01.002. Epub 2011 Jan 18.

18.

New chimeric antimalarials with 4-aminoquinoline moiety linked to a tetraoxane skeleton.

Opsenica I, Opsenica D, Lanteri CA, Anova L, Milhous WK, Smith KS, Solaja BA.

J Med Chem. 2008 Oct 9;51(19):6216-9. doi: 10.1021/jm8006905. Epub 2008 Sep 6.

PMID:
18774792
19.

Recent advances in malaria drug discovery.

Lanteri CA, Johnson JD, Waters NC.

Recent Pat Antiinfect Drug Discov. 2007 Jun;2(2):95-114. Review.

PMID:
18221166
20.

The mitochondrion is a site of trypanocidal action of the aromatic diamidine DB75 in bloodstream forms of Trypanosoma brucei.

Lanteri CA, Tidwell RR, Meshnick SR.

Antimicrob Agents Chemother. 2008 Mar;52(3):875-82. Epub 2007 Dec 17.

21.

Utility of alkylaminoquinolinyl methanols as new antimalarial drugs.

Dow GS, Heady TN, Bhattacharjee AK, Caridha D, Gerena L, Gettayacamin M, Lanteri CA, Obaldia N 3rd, Roncal N, Shearer T, Smith PL, Tungtaeng A, Wolf L, Cabezas M, Yourick D, Smith KS.

Antimicrob Agents Chemother. 2006 Dec;50(12):4132-43. Epub 2006 Sep 11.

22.

Roles for the Trypanosoma brucei P2 transporter in DB75 uptake and resistance.

Lanteri CA, Stewart ML, Brock JM, Alibu VP, Meshnick SR, Tidwell RR, Barrett MP.

Mol Pharmacol. 2006 Nov;70(5):1585-92. Epub 2006 Aug 15.

PMID:
16912218
23.

DB75, a novel trypanocidal agent, disrupts mitochondrial function in Saccharomyces cerevisiae.

Lanteri CA, Trumpower BL, Tidwell RR, Meshnick SR.

Antimicrob Agents Chemother. 2004 Oct;48(10):3968-74.

Supplemental Content

Loading ...
Support Center